|
Volumn 61, Issue 6, 2008, Pages 366-378
|
Efficacy and safety of faropenem in pediatric patients with bacterial infectious diseases
a b c d e f d,g g h i j k l |
Author keywords
[No Author keywords available]
|
Indexed keywords
AMOXICILLIN;
AMOXICILLIN PLUS CLAVULANIC ACID;
AMPICILLIN;
AZITHROMYCIN;
BETA LACTAM ANTIBIOTIC;
CEFCAPENE;
CEFDINIR;
CEFDITOREN;
CEFTERAM;
CEPHEM;
CLARITHROMYCIN;
FROPENEM;
PENICILLIN G;
TOSUFLOXACIN;
ANTIBACTERIAL ACTIVITY;
ARTICLE;
BACTERIAL INFECTION;
BRONCHITIS;
CHILD;
CHILDHOOD DISEASE;
CONTROLLED STUDY;
DIARRHEA;
DRUG EFFICACY;
DRUG SAFETY;
ESCHERICHIA COLI;
GROUP A STREPTOCOCCAL INFECTION;
HAEMOPHILUS INFLUENZAE TYPE A;
HUMAN;
MAJOR CLINICAL STUDY;
MINIMUM INHIBITORY CONCENTRATION;
MORAXELLA CATARRHALIS;
OTITIS MEDIA;
PATIENT COMPLIANCE;
PENICILLIN RESISTANCE;
PHARYNGITIS;
STREPTOCOCCUS PNEUMONIA;
STREPTOCOCCUS PYOGENES;
TONSILLITIS;
TREATMENT DURATION;
URINARY TRACT INFECTION;
BETA-LACTAMS;
CHILD;
CHILD, PRESCHOOL;
DOSAGE FORMS;
DRUG RESISTANCE, BACTERIAL;
HUMANS;
OTITIS MEDIA;
RESPIRATORY TRACT INFECTIONS;
STREPTOCOCCUS PNEUMONIAE;
STREPTOCOCCUS PYOGENES;
TREATMENT OUTCOME;
URINARY TRACT INFECTIONS;
|
EID: 58849119929
PISSN: 03682781
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (5)
|
References (14)
|